Phase I study of bortezomib in refractory of relapsed acute leukemias
- Jorge Cortes
- , Deborah Thomas
- , Charles Koller
- , Francis Giles
- , Elihu Estey
- , Stefan Faderl
- , Guillermo Garcia-Manero
- , David McConkey
- , Gira Patel
- , Roberto Guerciolini
- , John Wright
- , Hagop Kantarjian
- Department of Cancer Biology
- Millennium Pharmaceuticals, Inc.
- National Cancer Institute (NCI)
Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review
191
Citations
(Scopus)